APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibiotics Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antibiotics Drugs Market Outlook and Growth Opportunities 2026

20 December 2025209 pages

Choose your research edition.

Industry ResearchAntibiotics Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibiotics Drugs Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Antibiotics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibiotics Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibiotics Drugs Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Antibiotics Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antibiotics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antibiotics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antibiotics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antibiotics Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antibiotics Drugs market include GSK, Zhuhai Federal Pharmaceutical, Southwest Pharmaceutical, Sun Pharmaceutical, Shijiazhuang Pharmaceutical Group, Shenzhen Xinlitai Pharmaceutical, Shandong Anxin Pharmaceutical, Ruiyang Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Antibiotics Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antibiotics Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antibiotics Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Antibiotics Drugs market.

Antibiotics Drugs Segment by Company

GSK

Zhuhai Federal Pharmaceutical

Southwest Pharmaceutical

Sun Pharmaceutical

Shijiazhuang Pharmaceutical Group

Shenzhen Xinlitai Pharmaceutical

Shandong Anxin Pharmaceutical

Ruiyang Pharmaceutical

Pfizer

North China Pharmaceutical

Hainan Hailing Chemical Pharmaceutical Co., Ltd.

Sinopharm Zhijun

Guangzhou Baiyunshan

Fresenius

AbbVie

Sumitomo Pharma

Shionogi & Co Ltd

Sandoz

Merck & Co

Hikma Pharmaceuticals

Antibiotics Drugs Segment by Type

Oral

Injection

Antibiotics Drugs Segment by Application

Hospitals

Retail Pharmacy

Other

Antibiotics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Antibiotics Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Antibiotics Drugs key companies, revenue, market share, and recent developments.

3. To split the Antibiotics Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Antibiotics Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antibiotics Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Antibiotics Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibiotics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antibiotics Drugs industry.

Chapter 3: Detailed analysis of Antibiotics Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Antibiotics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Antibiotics Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antibiotics Drugs Industry Trends Table 2. Antibiotics Drugs Industry Drivers Table 3. Antibiotics Drugs Industry Opportunities and Challenges Table 4. Antibiotics Drugs Industry Restraints Table 5. Global Antibiotics Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antibiotics Drugs Revenue Share by Company (2021-2026) Table 7. Global Antibiotics Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Antibiotics Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Antibiotics Drugs Company, Product Type & Application Table 10. Global Antibiotics Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Antibiotics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oral Table 15. Significant Companies of Injection Table 16. Global Antibiotics Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Antibiotics Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Antibiotics Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Antibiotics Drugs Sales Value Share by Type (2021-2026) Table 20. Global Antibiotics Drugs Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Retail Pharmacy Table 23. Significant Companies of Other Table 24. Global Antibiotics Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Antibiotics Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Antibiotics Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Antibiotics Drugs Sales Value Share by Application (2021-2026) Table 28. Global Antibiotics Drugs Sales Value Share by Application (2027-2032) Table 29. Global Antibiotics Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Antibiotics Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Antibiotics Drugs Sales Value Share by Region (2021-2026) Table 32. Global Antibiotics Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Antibiotics Drugs Sales Value Share by Region (2027-2032) Table 34. Global Antibiotics Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Antibiotics Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Antibiotics Drugs Sales Value Market Share by Country (2021-2026) Table 37. Global Antibiotics Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Antibiotics Drugs Sales Value Market Share by Country (2027-2032) Table 39. GSK Company Information Table 40. GSK Business Overview Table 41. GSK Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. GSK Antibiotics Drugs Product Portfolio Table 43. GSK Recent Development Table 44. Zhuhai Federal Pharmaceutical Company Information Table 45. Zhuhai Federal Pharmaceutical Business Overview Table 46. Zhuhai Federal Pharmaceutical Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Zhuhai Federal Pharmaceutical Antibiotics Drugs Product Portfolio Table 48. Zhuhai Federal Pharmaceutical Recent Development Table 49. Southwest Pharmaceutical Company Information Table 50. Southwest Pharmaceutical Business Overview Table 51. Southwest Pharmaceutical Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Southwest Pharmaceutical Antibiotics Drugs Product Portfolio Table 53. Southwest Pharmaceutical Recent Development Table 54. Sun Pharmaceutical Company Information Table 55. Sun Pharmaceutical Business Overview Table 56. Sun Pharmaceutical Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Sun Pharmaceutical Antibiotics Drugs Product Portfolio Table 58. Sun Pharmaceutical Recent Development Table 59. Shijiazhuang Pharmaceutical Group Company Information Table 60. Shijiazhuang Pharmaceutical Group Business Overview Table 61. Shijiazhuang Pharmaceutical Group Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Shijiazhuang Pharmaceutical Group Antibiotics Drugs Product Portfolio Table 63. Shijiazhuang Pharmaceutical Group Recent Development Table 64. Shenzhen Xinlitai Pharmaceutical Company Information Table 65. Shenzhen Xinlitai Pharmaceutical Business Overview Table 66. Shenzhen Xinlitai Pharmaceutical Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Shenzhen Xinlitai Pharmaceutical Antibiotics Drugs Product Portfolio Table 68. Shenzhen Xinlitai Pharmaceutical Recent Development Table 69. Shandong Anxin Pharmaceutical Company Information Table 70. Shandong Anxin Pharmaceutical Business Overview Table 71. Shandong Anxin Pharmaceutical Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shandong Anxin Pharmaceutical Antibiotics Drugs Product Portfolio Table 73. Shandong Anxin Pharmaceutical Recent Development Table 74. Ruiyang Pharmaceutical Company Information Table 75. Ruiyang Pharmaceutical Business Overview Table 76. Ruiyang Pharmaceutical Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Ruiyang Pharmaceutical Antibiotics Drugs Product Portfolio Table 78. Ruiyang Pharmaceutical Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pfizer Antibiotics Drugs Product Portfolio Table 83. Pfizer Recent Development Table 84. North China Pharmaceutical Company Information Table 85. North China Pharmaceutical Business Overview Table 86. North China Pharmaceutical Antibiotics Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. North China Pharmaceutical Antibiotics Drugs Product Portfolio Table 88. North China Pharmaceutical Recent Development Table 89. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information Table 90. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview Table 91. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Antibiotics Drugs Product Portfolio Table 93. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Development Table 94. Sinopharm Zhijun Company Information Table 95. Sinopharm Zhijun Business Overview Table 96. Sinopharm Zhijun Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sinopharm Zhijun Antibiotics Drugs Product Portfolio Table 98. Sinopharm Zhijun Recent Development Table 99. Guangzhou Baiyunshan Company Information Table 100. Guangzhou Baiyunshan Business Overview Table 101. Guangzhou Baiyunshan Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Guangzhou Baiyunshan Antibiotics Drugs Product Portfolio Table 103. Guangzhou Baiyunshan Recent Development Table 104. Fresenius Company Information Table 105. Fresenius Business Overview Table 106. Fresenius Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Fresenius Antibiotics Drugs Product Portfolio Table 108. Fresenius Recent Development Table 109. AbbVie Company Information Table 110. AbbVie Business Overview Table 111. AbbVie Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. AbbVie Antibiotics Drugs Product Portfolio Table 113. AbbVie Recent Development Table 114. Sumitomo Pharma Company Information Table 115. Sumitomo Pharma Business Overview Table 116. Sumitomo Pharma Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sumitomo Pharma Antibiotics Drugs Product Portfolio Table 118. Sumitomo Pharma Recent Development Table 119. Shionogi & Co Ltd Company Information Table 120. Shionogi & Co Ltd Business Overview Table 121. Shionogi & Co Ltd Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Shionogi & Co Ltd Antibiotics Drugs Product Portfolio Table 123. Shionogi & Co Ltd Recent Development Table 124. Sandoz Company Information Table 125. Sandoz Business Overview Table 126. Sandoz Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Sandoz Antibiotics Drugs Product Portfolio Table 128. Sandoz Recent Development Table 129. Merck & Co Company Information Table 130. Merck & Co Business Overview Table 131. Merck & Co Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Merck & Co Antibiotics Drugs Product Portfolio Table 133. Merck & Co Recent Development Table 134. Hikma Pharmaceuticals Company Information Table 135. Hikma Pharmaceuticals Business Overview Table 136. Hikma Pharmaceuticals Antibiotics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Hikma Pharmaceuticals Antibiotics Drugs Product Portfolio Table 138. Hikma Pharmaceuticals Recent Development Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Antibiotics Drugs Product Image Figure 2. Global Antibiotics Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibiotics Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Antibiotics Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oral Image Figure 8. Injection Image Figure 9. Global Antibiotics Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Antibiotics Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Antibiotics Drugs Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Retail Pharmacy Image Figure 14. Other Image Figure 15. Global Antibiotics Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Antibiotics Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Antibiotics Drugs Sales Value Share by Application (2021-2032) Figure 18. Global Antibiotics Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Antibiotics Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Antibiotics Drugs Sales Value (2021-2032) & (US$ Million) Figure 21. North America Antibiotics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Antibiotics Drugs Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Antibiotics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Antibiotics Drugs Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Antibiotics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Antibiotics Drugs Sales Value (2021-2032) & (US$ Million) Figure 27. South America Antibiotics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Antibiotics Drugs Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Antibiotics Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Antibiotics Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospitals
  • Retail Pharmacy
  • Other
Companies covered
  • GSK
  • Zhuhai Federal Pharmaceutical
  • Southwest Pharmaceutical
  • Sun Pharmaceutical
  • Shijiazhuang Pharmaceutical Group
  • Shenzhen Xinlitai Pharmaceutical
  • Shandong Anxin Pharmaceutical
  • Ruiyang Pharmaceutical
  • Pfizer
  • North China Pharmaceutical
  • Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  • Sinopharm Zhijun
  • Guangzhou Baiyunshan
  • Fresenius
  • AbbVie
  • Sumitomo Pharma
  • Shionogi & Co Ltd
  • Sandoz
  • Merck & Co
  • Hikma Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antibiotics Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antibiotics Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Antibiotics Drugs Market Dynamics
  1. 2.1 Antibiotics Drugs Industry Trends
  2. 2.2 Antibiotics Drugs Industry Drivers
  3. 2.3 Antibiotics Drugs Industry Opportunities and Challenges
  4. 2.4 Antibiotics Drugs Industry Restraints
3 Antibiotics Drugs Market by Company
  1. 3.1 Global Antibiotics Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Antibiotics Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Antibiotics Drugs Company Ranking (2024-2026)
  4. 3.4 Global Antibiotics Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Antibiotics Drugs Company Product Type and Application
  6. 3.6 Global Antibiotics Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Antibiotics Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Antibiotics Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Antibiotics Drugs Market by Type
  1. 4.1 Antibiotics Drugs Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Antibiotics Drugs Sales Value by Type
  5. 4.2.1 Global Antibiotics Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Antibiotics Drugs Sales Value by Type (2021-2032)
  7. 4.2.3 Global Antibiotics Drugs Sales Value Share by Type (2021-2032)
5 Antibiotics Drugs Market by Application
  1. 5.1 Antibiotics Drugs Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Antibiotics Drugs Sales Value by Application
  6. 5.2.1 Global Antibiotics Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antibiotics Drugs Sales Value by Application (2021-2032)
  8. 5.2.3 Global Antibiotics Drugs Sales Value Share by Application (2021-2032)
6 Antibiotics Drugs Regional Value Analysis
  1. 6.1 Global Antibiotics Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antibiotics Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Antibiotics Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Antibiotics Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antibiotics Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Antibiotics Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Antibiotics Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Antibiotics Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Antibiotics Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Antibiotics Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Antibiotics Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Antibiotics Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Antibiotics Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Antibiotics Drugs Sales Value Share by Country, 2025 VS 2032
7 Antibiotics Drugs Country-level Value Analysis
  1. 7.1 Global Antibiotics Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antibiotics Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Antibiotics Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Antibiotics Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Antibiotics Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Antibiotics Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Antibiotics Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Antibiotics Drugs Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Zhuhai Federal Pharmaceutical
  8. 8.2.1 Zhuhai Federal Pharmaceutical Company Information
  9. 8.2.2 Zhuhai Federal Pharmaceutical Business Overview
  10. 8.2.3 Zhuhai Federal Pharmaceutical Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhuhai Federal Pharmaceutical Antibiotics Drugs Product Portfolio
  12. 8.2.5 Zhuhai Federal Pharmaceutical Recent Developments
  13. 8.3 Southwest Pharmaceutical
  14. 8.3.1 Southwest Pharmaceutical Company Information
  15. 8.3.2 Southwest Pharmaceutical Business Overview
  16. 8.3.3 Southwest Pharmaceutical Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Southwest Pharmaceutical Antibiotics Drugs Product Portfolio
  18. 8.3.5 Southwest Pharmaceutical Recent Developments
  19. 8.4 Sun Pharmaceutical
  20. 8.4.1 Sun Pharmaceutical Company Information
  21. 8.4.2 Sun Pharmaceutical Business Overview
  22. 8.4.3 Sun Pharmaceutical Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharmaceutical Antibiotics Drugs Product Portfolio
  24. 8.4.5 Sun Pharmaceutical Recent Developments
  25. 8.5 Shijiazhuang Pharmaceutical Group
  26. 8.5.1 Shijiazhuang Pharmaceutical Group Company Information
  27. 8.5.2 Shijiazhuang Pharmaceutical Group Business Overview
  28. 8.5.3 Shijiazhuang Pharmaceutical Group Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shijiazhuang Pharmaceutical Group Antibiotics Drugs Product Portfolio
  30. 8.5.5 Shijiazhuang Pharmaceutical Group Recent Developments
  31. 8.6 Shenzhen Xinlitai Pharmaceutical
  32. 8.6.1 Shenzhen Xinlitai Pharmaceutical Company Information
  33. 8.6.2 Shenzhen Xinlitai Pharmaceutical Business Overview
  34. 8.6.3 Shenzhen Xinlitai Pharmaceutical Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shenzhen Xinlitai Pharmaceutical Antibiotics Drugs Product Portfolio
  36. 8.6.5 Shenzhen Xinlitai Pharmaceutical Recent Developments
  37. 8.7 Shandong Anxin Pharmaceutical
  38. 8.7.1 Shandong Anxin Pharmaceutical Company Information
  39. 8.7.2 Shandong Anxin Pharmaceutical Business Overview
  40. 8.7.3 Shandong Anxin Pharmaceutical Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shandong Anxin Pharmaceutical Antibiotics Drugs Product Portfolio
  42. 8.7.5 Shandong Anxin Pharmaceutical Recent Developments
  43. 8.8 Ruiyang Pharmaceutical
  44. 8.8.1 Ruiyang Pharmaceutical Company Information
  45. 8.8.2 Ruiyang Pharmaceutical Business Overview
  46. 8.8.3 Ruiyang Pharmaceutical Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ruiyang Pharmaceutical Antibiotics Drugs Product Portfolio
  48. 8.8.5 Ruiyang Pharmaceutical Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Antibiotics Drugs Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 North China Pharmaceutical
  56. 8.10.1 North China Pharmaceutical Company Information
  57. 8.10.2 North China Pharmaceutical Business Overview
  58. 8.10.3 North China Pharmaceutical Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  59. 8.10.4 North China Pharmaceutical Antibiotics Drugs Product Portfolio
  60. 8.10.5 North China Pharmaceutical Recent Developments
  61. 8.11 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  62. 8.11.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Antibiotics Drugs Product Portfolio
  66. 8.11.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Sinopharm Zhijun
  68. 8.12.1 Sinopharm Zhijun Company Information
  69. 8.12.2 Sinopharm Zhijun Business Overview
  70. 8.12.3 Sinopharm Zhijun Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sinopharm Zhijun Antibiotics Drugs Product Portfolio
  72. 8.12.5 Sinopharm Zhijun Recent Developments
  73. 8.13 Guangzhou Baiyunshan
  74. 8.13.1 Guangzhou Baiyunshan Company Information
  75. 8.13.2 Guangzhou Baiyunshan Business Overview
  76. 8.13.3 Guangzhou Baiyunshan Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Guangzhou Baiyunshan Antibiotics Drugs Product Portfolio
  78. 8.13.5 Guangzhou Baiyunshan Recent Developments
  79. 8.14 Fresenius
  80. 8.14.1 Fresenius Company Information
  81. 8.14.2 Fresenius Business Overview
  82. 8.14.3 Fresenius Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Fresenius Antibiotics Drugs Product Portfolio
  84. 8.14.5 Fresenius Recent Developments
  85. 8.15 AbbVie
  86. 8.15.1 AbbVie Company Information
  87. 8.15.2 AbbVie Business Overview
  88. 8.15.3 AbbVie Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AbbVie Antibiotics Drugs Product Portfolio
  90. 8.15.5 AbbVie Recent Developments
  91. 8.16 Sumitomo Pharma
  92. 8.16.1 Sumitomo Pharma Company Information
  93. 8.16.2 Sumitomo Pharma Business Overview
  94. 8.16.3 Sumitomo Pharma Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sumitomo Pharma Antibiotics Drugs Product Portfolio
  96. 8.16.5 Sumitomo Pharma Recent Developments
  97. 8.17 Shionogi & Co Ltd
  98. 8.17.1 Shionogi & Co Ltd Company Information
  99. 8.17.2 Shionogi & Co Ltd Business Overview
  100. 8.17.3 Shionogi & Co Ltd Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Shionogi & Co Ltd Antibiotics Drugs Product Portfolio
  102. 8.17.5 Shionogi & Co Ltd Recent Developments
  103. 8.18 Sandoz
  104. 8.18.1 Sandoz Company Information
  105. 8.18.2 Sandoz Business Overview
  106. 8.18.3 Sandoz Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sandoz Antibiotics Drugs Product Portfolio
  108. 8.18.5 Sandoz Recent Developments
  109. 8.19 Merck & Co
  110. 8.19.1 Merck & Co Company Information
  111. 8.19.2 Merck & Co Business Overview
  112. 8.19.3 Merck & Co Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Merck & Co Antibiotics Drugs Product Portfolio
  114. 8.19.5 Merck & Co Recent Developments
  115. 8.20 Hikma Pharmaceuticals
  116. 8.20.1 Hikma Pharmaceuticals Company Information
  117. 8.20.2 Hikma Pharmaceuticals Business Overview
  118. 8.20.3 Hikma Pharmaceuticals Antibiotics Drugs Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Hikma Pharmaceuticals Antibiotics Drugs Product Portfolio
  120. 8.20.5 Hikma Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst